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The Typical Human Gene 
Apart from the DNA sequences that 
can be translated into the 
corresponding protein, the gene 
contains or is related to other 
sequences that control its function 
and expression. Just upstream of the 
start codon there is a region that is 
called the promoter region. This area 
controls (promotes) the expression 
of the corresponding gene. Other 
sequences, this time downstream 
from the last codon, can also exert: 
control on the gene transcription 
(enhancing mRNA production). Other 
important areas are the 5' and 3' 
untranslated regions, the former 
playing a major role in the control 
of mRNA translation whilst the latter 
has an important role in mRNA 
stability. These regions interact with 
proteins that are produced by other 
genes to control the temporal 
expression of the gene. Thus, the 
expression of a particular gene is 
under the influence of other genes 
within the genome. The rest of the 
gene is then divided into translated 
parts (exons) with intervening, non 
translated parts (introns). Prior to 
translation, the introns have to be 
removed (spliced) so that the final 
mRNA is translated into the protein 
of interest. Thus, specific sequences 
that are recognised by the splicing 
enzyme are present at intron/exon 
junctions. Another aspect of human 
genes is that the size can vary from 
small genes, with a small number of 
exons (less that 2000 bases, less than 
4 exons) to large genes with a large 
number of exons (more that 
1,000,000 bases and more than 30 
exons). 
What constitutes a Genetic 
disorder? 
Though both environmental and 
genetic factors play a role in the 
development of any disease, the 
definition of a genetic disorder is 
that of a disease caused by abnormal 
differences in an individual's 
genome. Genetic disorders can be 
broadly classified in 4 groups: 
(1) Single-gene (Mendelian or 
monogenic) - Single gene disorders are 
due to mutations in the DNA sequence 
of one gene. This mutation would result 
in either a low quantity of the related 
protein or the production of an abnormal 
protein that would result in a lack of 
function of the particular protein. There 
are over 6,000 identified single-gene 
disorders with an overall incidence of 
about lout of every 200 births. Some 
examples are cystic fibrosis, thalassaemia, 
Marfan syndrome, Huntington's disease, 
Dllrh<'nnp Mll~(,lllflr Dystrophy (lnd 
hereditary hemochromatosis. 
Single gene disorders are inherited 
in a recognizable pattern -
autosomal dominant, autosomal 
recessive and X-linked . In 
autosomal dominant conditions, the 
inheritance of a single mutant allele 
from either parent would result in 
the appearance of the disease. A 
typical example is Huntington's 
Disease. In autosomal recessive 
cOlH.litlollS, the condition would only 
manifest itself if two mutant alleles 
are inherited, one from each parent 
(thus these would be healthy 
carriers). A typical example of this 
condition would be cystic fibrosis 
and thalassaemia. In X-linked 
disorders, the gene of interest 
resides within the X-chromosomes. 
Thus the disease would usually 
manifest itself in the male progeny 
of carrier females. Duchene and 
Becker's muscular dystrophy are 
typical examples of these types of 
genetic disorders. 
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(2) Multifactorial (complex or 
polygenic) - This type of genetic 
condition is by far the most common 
type as this constitutes most if not 
all of the chronic and malignant 
disorders (including the 
susceptibility of infectious 
disorders). In this class of disorders, 
a number of environmental factors 
and mutations within multiple genes 
interact together to give rise to the 
phenotypical picture. Its more 
complicated nature makes it much 
more difficult to identify it as a 
genetic disorder especially when 
data on the extended family is not 
available. An example of this 
condition is Coeliac disease where 
a clear environment factor (gliadin 
fraction of the gluten molecule) and 
genes present on chromosomes 6 
(HLA complex), 5 and 19 and the 
CD28/CTLA4/ICOS gene cluster 
on chromosome 2 and other as yet 
to be identified environmental and 
genetic loci, interact in a still poorly 
understood way to give rise to the 
condition. Other examples include 
breast cancer susceptibility where 
genes on chromosomes 6, 11, 13, 
14, 15, 17 and 22 have been 
implicated, heart disease, high blood 
pressure, Alzheimer's disease, 
arthritis, diabetes, cancer and 
obesity. 
(3) Chromosomal - In this group 
of disorders, one finds that large 
sections of individual chromosomes 
are missing, duplicated or 
abnormally rejoined (translocations) 
and thus result in congenital disease . 
Most of the major chromosomal 
ahnormalities can be detected by 
microscopic examination . In most 
cases the disorder presents at birth 
in the form of a syndrome. Trisomy 
21 (or Down syndrome) is a 
common disorder that occurs when 
a person has three copies of 
chromosome 21. 
(4) Mitochondrial -
Mitochondria are vestiges of an 
archeobacterium which were 
progressively inserted in the cell 
during evolution. This organelle 
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Typical Human Gene (The beta globin gene on chromosome 11) 
contains its own, distinct DNA 
(circular in form) that encodes 37 
genes. Mutations within the 
mitochondrial DNA have been 
implicated in a number of disorders 
including cardiomyopathy, diabetes, 
Friedrich's Ataxia and optic 
neuropathy. 
Though the knowledge and 
technology have reached a stage that 
enable molecular geneticists to study 
polygenic disorders in an attempt to 
isolate the causative genes and thus 
produce clinically applicable tests, up 
to this date, this is still in its infancy 
and molecular geneticists are normally 
faced with the rarer, but easier to 
define, single gene disorders. Even in 
these conditions, identifying the 
causative mutations followed by 
counselling is fraught with 
interpretative problems. 8J 
Bibliography 
Ashtar A. Molecular Pathology of 
Infantile GM1-ganglioasidosis. 
Malta: University of Malta, 1998. 
Avery aT, Macleod CM, McCarty 
M. Studies on the Chemical Nature of 
the Substance Inducing Transformation 
of Pneumococcal Types. 1 Exp Med 
1944; 79:137-58.1944. 
Bezzina-Wettinger S, Balim Z, 
Felice AE. Allele Frequencies of 
selected polymorphisms related to 
thrombosis in the Maltese 
Population. Blood 2000; 96 part 2: 
94b. 
Farrugia R, Scerri CA, Montalto 
SA, Parascandolo R, Neville BG, 
Felice AE. Molecular genetics of 
tetrahydrobiopterin (BH4) 
deficiency in the Maltese 
population. Mol Genet Metab 2007; 
90(3):277-83. 
Franklin RE, Gosling RG. 
Evidence for 2-chain helix in 
crystalline structure of sodium 
deoxyribonucleate. Nature 
1953; 172(4369): 156-7. 
Galdies R, Pullicino E, Cassar W, 
Bezzina-Wettinger S, Borg J, Felice 
AE. A first study on the frequency 
and phenotypic effects of HFE gene 
mutations in the Maltese population. 
Malta Medical lournal 2006; 
18rSupplementl 
Kellogg DA, Doctor BP, Loebel 
JE, Nirenberg MW. RNA codons 
and protein synthesis . IX. Synonym 
codon recognition by multiple 
species of valine-, alanine-, and 
methionine-sRNA. Proc Natl Acad 
Sci USA 1966; 55(4):912-9. 
Mullis K, Faloona F, Scharf S, 
Saiki R, Horn G, Erlich H. Specific 
enzymatic ampl ification of DNA in 
vitro: the polymerase chain reaction. 
Cold Spring Harb Symp Quant Bioi 
1986;51 Pt 1:263-73. 
Scerri CA. Clinical and Molecular 
Pathology of the beta+ IVSI-6C 
Thalassaemia in Malta. Malta: 
University of Malta, 1998. 
Vella J. The Detection of the DNA 
Mutations that Cause 
Gangliosidosis. Malta: University 
of Malta , 2000. 
Watson JD, Crick FH. The 
structure of DNA. Cold Spring Harb 
Symp Quant Biv1195J, 18 .123-31. 
Wilkins MH, Seeds WE, Stokes AR, 
Wilson HR. Helical structure of 
crystalline deoxypentose nucleic acid. 
Nature 1953;172(4382):759-62. 
~ ~ TheSynap&e 
~ 
